TNF-α -863 polymorphisms and the risk of hepatocellular carcinoma
- Authors:
- Yan Yang
- Xiao-Qiang Qiu
- Hong-Ping Yu
- Xiao-Yun Zeng
- Chun-Hua Bei
View Affiliations
Affiliations: Department of Epidemiology, School of Public Health, Guangxi Medical University, Nanning, P.R. China, School of Public Health, Guilin Medical University, Guilin, Guangxi, P.R. China
- Published online on: December 15, 2011 https://doi.org/10.3892/etm.2011.418
-
Pages:
513-518
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Hepatocellular carcinoma (HCC) is a common type of highly malignant tumor. Guangxi is an area of China characterized by a high incidence of HCC. Previous epidemiological studies have found that chronic infection with hepatitis B virus (HBV) is one of the major etiological risk factors for HCC in China. With the increased understanding of the host immune response against HBV and the pathogenesis of the virus, at present, greater attention is being given to the immune response of cytokine genes, as polymorphisms may have a major impact on the course and outcome of HBV infection. In the present study, we genotyped tumor necrosis factor-α (TNF-α) rs1800629 (-308G/A), rs1800630 (-863C/A); interleukin-1B rs1143627 (-31T/C); and transforming growth factor β1 (TGF-β1) rs1800469 (-509C/T) in a hospital-based study of 772 HCC cases and 852 cancer-free controls. The distribution of the frequency of TNF-α rs1800630 sites of CC, CA, AA were 65.67, 27.46 and 6.87% in the case group, respectively, as compared with 67.02, 29.58 and 3.40% in the controls, all with a statistical significance (P<0.05). The logistic regression analysis revealed that the variant rs1800630 AA genotypes were associated with a significantly increasing risk of HCC (OR=2.058, 95% CI 1.289-3.287), compared with the wild-type rs1800630 CC. Further stratified analyses showed that after stratification for history of alcohol drinking, in a subgroup of individuals without a history of drinking, the HCC risk in the group with the TNF-α rs1800630 A allele was 1.839 times higher than that in the group with TNF-α rs1800630 C (P<0.010). These findings suggest that TNF-α rs1800630 may contribute to the risk of HCC, however, these data require further validation.
View References
|
1.
|
DM ParkinF BrayJ FerlayP PisaniGlobal
cancer statistics, 2002CA Cancer J
Clin5574108200510.3322/canjclin.55.2.74
|
|
2.
|
MJ ThunJO DeLanceyMM CenterThe global
burden of cancer: priorities for
preventionCarcinogenesis31100110201010.1093/carcin/bgp26319934210
|
|
3.
|
C ZhangT HuangJ YuEpidemiological analysis
of primary liver cancer in the early 21st century in Guangxi
province of ChinaChin J Cancer29545550201010.5732/cjc.009.10510
|
|
4.
|
FS YehKN ShenEpidemiology and early
diagnosis of primary liver cancer in ChinaAdv Cancer
Res47297329198610.1016/S0065-230X(08)60203-12430432
|
|
5.
|
JD GroopmanJS WangP SchollMolecular
biomarkers for aflatoxins: from adducts to gene mutations to human
liver cancerCan J Physiol Pharmacol7420320919968723033
|
|
6.
|
V ThakurRC GuptanSN KazimProfile,
sepectrum and significance of HBV genotypes in chronic liver
disease patients in the Indian subcontinentJ Gastroenterol
Hepatol17165170200210.1046/j.1440-1746.2002.02605.x11966946
|
|
7.
|
AS LokEJ HeathcoteJH HoofnaqueManagement
of hepatitis B: 2000-summary of a
workshopGastroenterology12018281853200110.1053/gast.2001.2483911375963
|
|
8.
|
S InoNatural history of hepatitis B and C
virus infectionOncology621823200210.1159/000048271
|
|
9.
|
A BudhuXW WangThe role of cytokines in
hepatocellular carcinomaJ Leukoc
Biol8011971213200610.1189/jlb.050629716946019
|
|
10.
|
C FerrariA PennaA BertolettiAntiviral
cell-mediated immune responses during hepatitis B and hepatitis C
virus infectionsRecent Results Cancer
Res154330336199810.1007/978-3-642-46870-4_2410027013
|
|
11.
|
GN VgasImmunobiology of persistent
blood-borne viral infectionsDev Biol102917200010794086
|
|
12.
|
SY HoYJ WangHL ChenIncreased risk of
developing hepatocellular carcinoma associated with carriage of the
TNF2 allele of the -308 tumor necrosis factor-α promoter geneCancer
Causes Control15657663200415280623
|
|
13.
|
Y WangN KatoY HoshidaInterleukin-1B gene
polymorphisms associated with hepatocellular carcinoma in hepatitis
C virus
infectionHepatology376571200310.1053/jhep.2003.5001712500190
|
|
14.
|
YJ KimHS LeeJP ImAssociation of
transforming growth factor-beta1 gene polymorphisms with a
hepatocellular carcinoma risk in patients with chronic hepatitis B
virus infectionExp Mol
Med35196202200310.1038/emm.2003.2712858019
|
|
15.
|
P QiYM ChenH Wang-509C>T polymorphism
in the TGF-β1 gene promoter, impact on the hepatocellular carcinoma
risk in Chinese patients with chronic hepatitis B virus
infectionCancer Immunol Immunother58143314402009
|
|
16.
|
T SkoogFM HooftB KallinA common functional
polymorphism (C→A substitution at position -863) in the promoter
region of the tumour necrosis factor-alpha (TNF-alpha) gene
associated with reduced circulating levels of TNF-alphaHum Mol
Genet8144314491999
|
|
17.
|
PC KaoJF WuYH NiTumour necrosis
factor-alpha promoter region polymorphisms affect the course of
spontaneous HBsAg clearanceLiver
Int3014481453201010.1111/j.1478-3231.2010.02340.x
|
|
18.
|
P KummeeP TangkijvanichY
PoovorawanAssociation of HLA-DRB1*13 and TNF-alpha gene
polymorphisms with clearance of chronic hepatitis B infection and
risk of hepatocellular carcinoma in Thai populationJ Viral
Hepat14841848200718070287
|
|
19.
|
Q XiaL ZhouD LiuRelationship between
TNF-<alpha> gene promoter polymorphisms and outcomes of
hepatitis B virus infections: a meta-analysisPLoS
One6e196062011
|
